Latest News about SPRC
Recent news which mentions SPRC
The 7 Most Promising Penny Stocks to Buy in June
June 07, 2023
Tags
NASDAQ:REUN,NASDAQ:KXIN,NASDAQ:APLM,NASDAQ:MMV,NASDAQ:WLDS,NYSEAMERICAN:NNVC,NASDAQ:SPRC
SPRC
KXIN
From InvestorPlace
SciSparc Nutraceuticals Granted An Exclusive License For The Sales Of CannAmide On The Amazon Marketplace In Canada
June 07, 2023
From Benzinga
Why A National Cannabis Organization Sacked Half Its Staff, CEO Turnovers And More Exec Changes
June 05, 2023
From Benzinga
Why Guidewire Software Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Friday's Mid-Day Session
June 02, 2023
From Benzinga
New Drug Based On FDA-Approved Synthetic THC And CannAmide Shows Promise In Treating Agitation In Alzhemier's
June 02, 2023
Tickers
SPRC
From Benzinga
From InvestorPlace
Psyched: LSD For Major Depression, Canada's Psilocybin Macrodose Trial, Treatments For Multiple Sclerosis And More
April 24, 2023
From Benzinga
Why SAP Shares Are Trading Higher By Around 6%? Here Are Other Stocks Moving In Friday's Mid-Day Session
April 21, 2023
From Benzinga
SciSparc And Clearmind Collaboration Strengthens IP Portfolio With Patent Application For Treatment Of Depression
April 21, 2023
From Benzinga
Why Kalera Shares Are Trading Lower By Around 37%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
April 11, 2023
From Benzinga
From InvestorPlace
Stocks That Hit 52-Week Lows On Friday
March 31, 2023
From Benzinga
Stocks That Hit 52-Week Lows On Tuesday
March 28, 2023
From Benzinga
From InvestorPlace
SciSparc Completes Production Of Its Dronabinol-Based Drug Candidate For Its Clinical Trial On Tourette Syndrome
March 06, 2023
Tickers
SPRC
From Benzinga
Psyched: Hawaii And Minnesota's Bills, Studying 2C-B Vs. Psilocybin, Filament CEO, Plus Brock Pierce And Jeremy Gardner Discuss The Industry's Future And More
February 27, 2023
From Benzinga
SciSparc's CBD-Based Drug One Step Closer To Clinical Trial On Children With Autism Spectrum Disorder
February 27, 2023
Tickers
SPRC
From Benzinga
Jeffs' Brands To Acquire A 49% Interest In A Company That Owns A Top Seller Brand On Amazon For $2.5M
February 23, 2023
From Benzinga
SciSparc And Clearmind Reveal Three Unique Combinations Of Future Psychedelic-Based Compounds
February 22, 2023
From Benzinga
Why CVRx Shares Are Trading Lower By 43%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
February 21, 2023
From Benzinga
Why Owlet Shares Are Trading Higher By Over 45%; Here Are 20 Stocks Moving Premarket
February 21, 2023
From Benzinga
Why Universal Electronics Shares Are Trading Lower By 30%? Here Are Other Stocks Moving In Friday's Mid-Day Session
February 17, 2023
From Benzinga
Why Is SciSparc (SPRC) Stock Up 14% Today?
February 17, 2023
From InvestorPlace
Novel Combination Of Cannabis-Like Compound With Classical Psychedelics Searches IP Coverage In US
February 15, 2023
From Benzinga
Why Grom Social Enterprises Shares Are Trading Lower By 30%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
January 25, 2023
From Benzinga
Why Evoqua Water Technologies Shares Are Trading Higher By 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
January 23, 2023
From Benzinga
Envisioning A Cocaine-Addiction Treatment: This Next-Gen Psychedelic Shows Positive Results
January 18, 2023
From Benzinga
This Pharma Company Is Working With Israeli Medical Center To Research And Treat Autism With CBD
January 09, 2023
Tickers
SPRC
From Benzinga
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.